Sara Nunnery
MD, MSCI
Director of Breast Cancer Research
Tennessee Oncology

Sessions

Register
General Session

Advancing Precision Care in HR+/HER2- Metastatic Breast Cancer: ESR1 Testing and the Expanding Role of Oral SERDs

Sunday, March 15, 2026
11:10 AM - 11:55 AM
General Session

Advancing Precision Care in HR+/HER2- Metastatic Breast Cancer: ESR1 Testing and the Expanding Role of Oral SERDs

Sunday, September 27, 2026
10:50 AM - 11:35 AM
Back to top